The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial

Garg, Scot; Serruys, Patrick W; Silber, Sigmund; Wykrzykowska, Joanna; van Geuns, Robert Jan; Richardt, Gert; Buszman, Pawel E; Kelbæk, Henning; van Boven, Adrianus Johannes; Hofma, Sjoerd H; Linke, Axel; Klauss, Volker; Wijns, William; Macaya, Carlos; Garot, Philippe; DiMario, Carlo; Manoharan, Ganesh; Kornowski, Ran; Ischinger, Thomas; Bartorelli, Antonio; ... (2011). The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC. Cardiovascular Interventions, 4(4), pp. 432-41. New York, N.Y.: Elsevier 10.1016/j.jcin.2011.01.008

Full text not available from this repository. (Request a copy)

This study assessed the ability of the SYNTAX score (SXscore) to stratify risk in patients treated with percutaneous coronary intervention (PCI) using zotarolimus-eluting or everolimus-eluting stents.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

ISSN:

1876-7605

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:21

Last Modified:

06 Mar 2014 22:43

Publisher DOI:

10.1016/j.jcin.2011.01.008

PubMed ID:

21511223

Web of Science ID:

000290128100008

URI:

https://boris.unibe.ch/id/eprint/7229 (FactScience: 212416)

Actions (login required)

Edit item Edit item
Provide Feedback